| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |